• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于探索构效关系。

On exploring structure-activity relationships.

作者信息

Guha Rajarshi

机构信息

NIH Center for Advancing Translational Science, Rockville, MD, USA.

出版信息

Methods Mol Biol. 2013;993:81-94. doi: 10.1007/978-1-62703-342-8_6.

DOI:10.1007/978-1-62703-342-8_6
PMID:23568465
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4852705/
Abstract

Understanding structure-activity relationships (SARs) for a given set of molecules allows one to rationally explore chemical space and develop a chemical series optimizing multiple physicochemical and biological properties simultaneously, for instance, improving potency, reducing toxicity, and ensuring sufficient bioavailability. In silico methods allow rapid and efficient characterization of SARs and facilitate building a variety of models to capture and encode one or more SARs, which can then be used to predict activities for new molecules. By coupling these methods with in silico modifications of structures, one can easily prioritize large screening decks or even generate new compounds de novo and ascertain whether they belong to the SAR being studied. Computational methods can provide a guide for the experienced user by integrating and summarizing large amounts of preexisting data to suggest useful structural modifications. This chapter highlights the different types of SAR modeling methods and how they support the task of exploring chemical space to elucidate and optimize SARs in a drug discovery setting. In addition to considering modeling algorithms, I briefly discuss how to use databases as a source of SAR data to inform and enhance the exploration of SAR trends. I also review common modeling techniques that are used to encode SARs, recent work in the area of structure-activity landscapes, the role of SAR databases, and alternative approaches to exploring SAR data that do not involve explicit model development.

摘要

了解给定分子集的构效关系(SARs)可以使人们合理地探索化学空间,并开发出一个能同时优化多种物理化学和生物学性质的化学系列,例如,提高效力、降低毒性并确保足够的生物利用度。计算机模拟方法能够快速、高效地表征构效关系,并有助于构建各种模型来捕捉和编码一种或多种构效关系,进而可用于预测新分子的活性。通过将这些方法与结构的计算机模拟修饰相结合,人们可以轻松地对大型筛选库进行优先级排序,甚至从头生成新化合物,并确定它们是否属于正在研究的构效关系。计算方法可以通过整合和总结大量已有的数据来为有经验的用户提供指导,以建议有用的结构修饰。本章重点介绍了不同类型的构效关系建模方法,以及它们如何支持在药物发现环境中探索化学空间以阐明和优化构效关系的任务。除了考虑建模算法外,我还简要讨论了如何将数据库用作构效关系数据的来源,以了解和加强对构效关系趋势的探索。我还回顾了用于编码构效关系的常见建模技术、构效关系景观领域的最新工作、构效关系数据库的作用,以及不涉及显式模型开发的探索构效关系数据的替代方法。

相似文献

1
On exploring structure-activity relationships.关于探索构效关系。
Methods Mol Biol. 2013;993:81-94. doi: 10.1007/978-1-62703-342-8_6.
2
Activity landscape of DNA methyltransferase inhibitors bridges chemoinformatics with epigenetic drug discovery.DNA甲基转移酶抑制剂的活性景观将化学信息学与表观遗传药物发现联系起来。
Expert Opin Drug Discov. 2015 Oct;10(10):1059-70. doi: 10.1517/17460441.2015.1073257. Epub 2015 Aug 1.
3
Capturing structure-activity relationships from chemogenomic spaces.从化学生物基因组空间中获取结构-活性关系。
J Chem Inf Model. 2011 Apr 25;51(4):843-51. doi: 10.1021/ci100270x. Epub 2011 Mar 16.
4
QSAR Methods.定量构效关系方法
Methods Mol Biol. 2016;1425:1-20. doi: 10.1007/978-1-4939-3609-0_1.
5
SAR Matrix Method for Large-Scale Analysis of Compound Structure-Activity Relationships and Exploration of Multitarget Activity Spaces.用于大规模分析化合物构效关系和探索多靶点活性空间的SAR矩阵方法。
Methods Mol Biol. 2018;1825:339-352. doi: 10.1007/978-1-4939-8639-2_11.
6
Structural interpretation of activity cliffs revealed by systematic analysis of structure-activity relationships in analog series.通过对类似物系列构效关系的系统分析揭示的活性断崖的结构解释。
J Chem Inf Model. 2009 Oct;49(10):2179-89. doi: 10.1021/ci900243a.
7
Reaching for the bright StARs in chemical space.在化学空间中追寻闪亮的 STARs。
Drug Discov Today. 2019 Nov;24(11):2162-2169. doi: 10.1016/j.drudis.2019.09.013. Epub 2019 Sep 23.
8
AutoDesigner - Core Design, a De Novo Design Algorithm for Chemical Scaffolds: Application to the Design and Synthesis of Novel Selective Wee1 Inhibitors.AutoDesigner - 核心设计,一种化学支架的从头设计算法:在新型选择性 Wee1 抑制剂的设计和合成中的应用。
J Chem Inf Model. 2024 Oct 14;64(19):7513-7524. doi: 10.1021/acs.jcim.4c01031. Epub 2024 Oct 3.
9
QSAR Methods.定量构效关系方法
Methods Mol Biol. 2022;2425:1-26. doi: 10.1007/978-1-0716-1960-5_1.
10
The Pharmacophore Network: A Computational Method for Exploring Structure-Activity Relationships from a Large Chemical Data Set.药效团网络:一种从大型化学数据集探索结构-活性关系的计算方法。
J Med Chem. 2018 Apr 26;61(8):3551-3564. doi: 10.1021/acs.jmedchem.7b01890. Epub 2018 Apr 18.

引用本文的文献

1
StackNAFLD: An Accurate Stacking Ensemble Learning Targeting NAFLD Treatment.StackNAFLD:一种针对非酒精性脂肪性肝病治疗的精确堆叠集成学习方法。
ACS Omega. 2025 Aug 15;10(33):37096-37114. doi: 10.1021/acsomega.5c01473. eCollection 2025 Aug 26.
2
A Beautiful Bind: Phage Display and the Search for Cell-Selective Peptides.一个美妙的困境:噬菌体展示与细胞选择性肽的探索
Viruses. 2025 Jul 12;17(7):975. doi: 10.3390/v17070975.
3
Digital Alchemy: The Rise of Machine and Deep Learning in Small-Molecule Drug Discovery.数字炼金术:小分子药物发现中机器学习与深度学习的兴起

本文引用的文献

1
Does your model weigh the same as a duck?你的模型和一只鸭子一样重吗?
J Comput Aided Mol Des. 2012 Jan;26(1):57-67. doi: 10.1007/s10822-011-9530-1. Epub 2011 Dec 21.
2
The inevitable QSAR renaissance.必然的定量构效关系复兴。
J Comput Aided Mol Des. 2012 Jan;26(1):35-8. doi: 10.1007/s10822-011-9495-0. Epub 2011 Nov 30.
3
Discovery of α7-nicotinic receptor ligands by virtual screening of the chemical universe database GDB-13.通过对化学宇宙数据库 GDB-13 的虚拟筛选发现 α7 烟碱型乙酰胆碱受体配体。
Int J Mol Sci. 2025 Jul 16;26(14):6807. doi: 10.3390/ijms26146807.
4
Target Engagement Assays in Early Drug Discovery.早期药物发现中的靶点结合分析
J Med Chem. 2025 Jun 26;68(12):12331-12368. doi: 10.1021/acs.jmedchem.4c03115. Epub 2025 Jun 4.
5
Quinoline Quest: Kynurenic Acid Strategies for Next-Generation Therapeutics via Rational Drug Design.喹啉探索:通过合理药物设计开发下一代治疗药物的犬尿喹啉酸策略
Pharmaceuticals (Basel). 2025 Apr 22;18(5):607. doi: 10.3390/ph18050607.
6
Rational Method for Structural Simplification as Key Step in Hit Discovery: The Case of FGFR2 and IGF1R Dual Inhibitors.结构简化的合理方法作为药物发现关键步骤:以FGFR2和IGF1R双重抑制剂为例
Int J Mol Sci. 2025 May 7;26(9):4457. doi: 10.3390/ijms26094457.
7
An approach to characterize mechanisms of action of anti-amyloidogenic compounds in vitro and in situ.一种在体外和原位表征抗淀粉样蛋白生成化合物作用机制的方法。
NPJ Parkinsons Dis. 2025 May 10;11(1):122. doi: 10.1038/s41531-025-00966-5.
8
Understanding the HIV-CA protein and the ligands that bind at the N-terminal domain (NTD) - C-terminal domain (CTD) interface.了解HIV衣壳蛋白以及在N端结构域(NTD)-C端结构域(CTD)界面结合的配体。
RSC Med Chem. 2025 Apr 17. doi: 10.1039/d5md00111k.
9
Structure-activity relationship guided design, synthesis and biological evaluation of novel diaryl urea derivatives as antiproliferative agents.基于构效关系指导的新型二芳基脲衍生物作为抗增殖剂的设计、合成及生物学评价
BMC Chem. 2025 Apr 22;19(1):107. doi: 10.1186/s13065-025-01478-2.
10
Computational analysis of antimicrobial peptides targeting key receptors in infection-related cardiovascular diseases: molecular docking and dynamics insights.针对感染相关心血管疾病关键受体的抗菌肽的计算分析:分子对接与动力学见解
Sci Rep. 2025 Mar 14;15(1):8896. doi: 10.1038/s41598-025-93683-1.
J Chem Inf Model. 2011 Dec 27;51(12):3105-12. doi: 10.1021/ci200410u. Epub 2011 Nov 22.
4
From activity cliffs to target-specific scoring models and pharmacophore hypotheses.从活动悬崖到目标特异性评分模型和药效团假说。
ChemMedChem. 2011 Sep 5;6(9):1630-9, 1533. doi: 10.1002/cmdc.201100179. Epub 2011 Jul 12.
5
Consensus models of activity landscapes with multiple chemical, conformer, and property representations.具有多种化学、构象和性质表示形式的活动景观共识模型。
J Chem Inf Model. 2011 Jun 27;51(6):1259-70. doi: 10.1021/ci200081k. Epub 2011 Jun 9.
6
A comparison of different QSAR approaches to modeling CYP450 1A2 inhibition.比较不同的定量构效关系方法在 CYP4501A2 抑制模型中的应用。
J Chem Inf Model. 2011 Jun 27;51(6):1271-80. doi: 10.1021/ci200091h. Epub 2011 May 20.
7
A comprehensive support vector machine binary hERG classification model based on extensive but biased end point hERG data sets.基于广泛但存在偏倚的终点 hERG 数据集的全面支持向量机二进制 hERG 分类模型。
Chem Res Toxicol. 2011 Jun 20;24(6):934-49. doi: 10.1021/tx200099j. Epub 2011 May 6.
8
Single R-Group Polymorphisms (SRPs) and R-cliffs: an intuitive framework for analyzing and visualizing activity cliffs in a single analog series.单 R-群多态性(SRPs)和 R-悬崖:用于分析和可视化单个模拟系列中活性悬崖的直观框架。
J Chem Inf Model. 2011 May 23;51(5):1122-31. doi: 10.1021/ci200054u. Epub 2011 Apr 19.
9
Synthesis and SAR studies of chiral non-racemic dexoxadrol analogues as uncompetitive NMDA receptor antagonists.手性非外消旋的右旋氧哒醇类似物作为非竞争性 NMDA 受体拮抗剂的合成及构效关系研究。
Bioorg Med Chem. 2010 Nov 15;18(22):7855-67. doi: 10.1016/j.bmc.2010.09.047. Epub 2010 Sep 25.
10
Scaffold explorer: an interactive tool for organizing and mining structure-activity data spanning multiple chemotypes.支架探索者:一种用于组织和挖掘跨越多种化学型结构活性数据的交互式工具。
J Med Chem. 2010 Jul 8;53(13):5002-11. doi: 10.1021/jm1004495.